Patents Examined by Qing Xu
  • Patent number: 10597629
    Abstract: There is disclosed a method for preparation of substrate for use in anaerobic digestion of organic waste. The method can be executed in a substrate pretreatment system, the method comprising: loading of a substrate into the substrate pretreatment system, mixing the substrate with liquid; heating the substrate and liquid to a pre-determined processing temperature; exposing the mixture to radiation; transferring the processed substrate to a bioreactor, during the heating, the method further comprises: degassing the mixture using vacuum extraction; and circulating the mixture past an ultrasonic hydrodynamic radiator.
    Type: Grant
    Filed: March 1, 2016
    Date of Patent: March 24, 2020
    Assignee: “BIOENERGY” LIMITED LIABILITY COMPANY
    Inventors: Aleksandr Andreevich Smotritckii, Andrey Vladimirovich Smotritskiy, Tatiana Andreevna Smotritskaya
  • Patent number: 10575516
    Abstract: Disclosed are products having animal tissue packed within the lumen of a device such as a needle cannula and being therein impregnated with a cryopreservation medium. The needle cannula or other device can be received in a capsule and/or other container, which in some forms can contain additional amounts of the cryopreservation medium occurring external of the lumen. Methods of use of the products are also described and can include ejecting the animal tissue from the lumen of device using pressurized liquid passed through the lumen, potentially to deliver the animal tissue directly into a patient. Methods of manufacture of the products are also described.
    Type: Grant
    Filed: November 14, 2018
    Date of Patent: March 3, 2020
    Assignee: Cook Biotech Incorporated
    Inventors: Umesh H. Patel, Michael L. Taylor, Claus Sondergaard, Cara McCammon, Rae Ritchie
  • Patent number: 10576110
    Abstract: The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of non-replicating L. johnsonii La1 NCC533 (deposit number CNCM I-1225) for use in the treatment or prevention of disorders related to the immune system including infections.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: March 3, 2020
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Valerie Petit, Clara Garcia-Rodenas, Monique Julita, Guenolee Prioult, Annick Mercenier, Sophie Nutten
  • Patent number: 10563167
    Abstract: Provided is a microorganism culture sheet having an excellent efficiency for collection of environmental microorganisms and a method for measuring the environmental microorganisms with an excellent collection efficiency. Provided is a microorganism culture sheet including a base sheet, a dry culture layer formed on the base sheet, and a cover sheet covering the dry culture layer, wherein an adhesive layer and a release film are laminated on the inner surface of the cover sheet. Because the environmental microorganisms are collected using the adhesive layer, an excellent collection efficiency is provided.
    Type: Grant
    Filed: January 26, 2011
    Date of Patent: February 18, 2020
    Assignee: Dai Nippon Printing Co., Ltd.
    Inventors: Shin-ichi Waku, Michiko Miyagi, Rui Saito, Tetsuji Ueki, Takuma Baba, Mai Kinoshita
  • Patent number: 10564077
    Abstract: A device and a method are provided for isolating a fraction in a biological sample. The fraction is bound to solid phase substrate to define a fraction-bound solid phase substrate. The device includes an input zone for receiving the biological sample therein to capture a desired fraction of the biological sample. A force is provided that is generally perpendicular to gravity. The force is movable between a first position adjacent the input zone multiple other positions adjacent various purification, protein analysis, separation and extraction zones. The force captures the fraction-bound solid phase substrate and the fraction-bound solid phase substrate moves from the input zone to the other zones to perform a multi-step assay on the isolated fraction within the device.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: February 18, 2020
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: David J. Beebe, Joshua M. Lang, Benjamin P. Casavant, Scott M. Berry, Lindsay N. Strotman
  • Patent number: 10533194
    Abstract: A system and method for converting biomass with no chemical pretreatment is disclosed. Combination of a microbial system and the use of mechanical disruption during fermentation may help achieve high conversion rate without the extra cost and undesirable by-products typically associated with the pretreatment process.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: January 14, 2020
    Assignee: THE TRUSTEES OF DARTMOUTH COLLEGE
    Inventors: Lee R. Lynd, Julie M. D. Paye, Michael Balch
  • Patent number: 10487349
    Abstract: A fluidic device (1) has a culture chamber (10) configured to house a 3D culture matrix (2) comprising a culture of microorganisms (6). A concentration gradient of a test substance is established over the 3D culture matrix (2) by providing respective fluid flows at different end portions (12, 14) of the culture chamber (10) and comprising different concentrations of the test substance. The response of the microorganisms (6) to the test substance is determined based on the position of a border zone (5) in the 3D culture matrix (2).
    Type: Grant
    Filed: July 10, 2014
    Date of Patent: November 26, 2019
    Assignee: GRADIENTECH AB
    Inventors: Johan Kreuger, Sara Thorslund, Zhigang Wu
  • Patent number: 10472664
    Abstract: Screening methods as well as systems and kits for identifying inhibitors of DNA-independent, histone H4-dependent activation of PARP-1 are provided. The methods comprise screening molecules for their capacity to inhibit the activation and/or biologic activity of PARP-1, as measured by poly(ADP)-ribose production from nicotinamide adenine dinucleotide. PARP-1 inhibitors identified through the screening methods may be used to treat cancer in which PARP-1 activation or biologic activity plays a role.
    Type: Grant
    Filed: September 30, 2015
    Date of Patent: November 12, 2019
    Assignee: Institute For Cancer Research
    Inventor: Alexei Tulin
  • Patent number: 10465209
    Abstract: The present invention relates to a process for production of fermentation products, including bioethanol by non-pressurized pre-treatment, enzymatic hydrolysis and fermentation of waste fractions containing mono- and/or polysaccharides, having a relatively high dry matter content. The process in its entirety, i.e. from non-pressurized pre-treatment over enzymatic hydrolysis and fermentation to sorting of fermentable and non-fermentable solids can be processed at a relatively high dry matter content in a single vessel or similar device using free fall mixing for the mechanical processing of the waste fraction.
    Type: Grant
    Filed: February 25, 2012
    Date of Patent: November 5, 2019
    Assignee: Renescience A/S
    Inventors: Nanna Dreyer Noerholm, Jan Larsen, Frank Krogh Iversen
  • Patent number: 10434150
    Abstract: Oral administration of ALV003 can protect celiac disease patients and patients otherwise suffering from gluten-intolerance from the harmful effects of ingesting food containing gluten.
    Type: Grant
    Filed: January 23, 2014
    Date of Patent: October 8, 2019
    Assignee: Immunogenics LLC
    Inventors: Bret Berner, Matthew John Siegel
  • Patent number: 10375955
    Abstract: Methodologies, formulations, and kits suitable for decontaminating environments containing bacterial spores by degrading the spores. Formulations contain papain and at least one germinant. Methods for killing bacterial spores include contacting the spores with the formulation for a duration sufficient to initiate germination of the bacterial spores. The spores are then killed with the papain in the formulation, or are rendered by the papain susceptible to being killed by a reagent.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: August 13, 2019
    Assignee: Loyola University Chicago
    Inventor: Adam Driks
  • Patent number: 10377649
    Abstract: The present invention relates to apparatus, methods, and applications for treating wastewater, and more particularly to biological processes for removing pollutants from wastewater. This invention further relates to apparatus and methods for growing microbes on-site at a wastewater treatment facility, and for economically inoculating sufficient microbes to solve various treatment problems rapidly.
    Type: Grant
    Filed: March 6, 2008
    Date of Patent: August 13, 2019
    Inventor: G. Robert Whiteman
  • Patent number: 10316290
    Abstract: The invention relates to methods for directing differentiation of stem cells comprising graphene. In additional embodiments, the invention relates to methods for repairing and improving bone tissue functions comprising accelerating differentiation in stem cell growth by exposing stem cells to graphene and transplanting the graphene with the exposed stem cells in the tissue at the site of repair.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: June 11, 2019
    Assignee: National University of Singapore
    Inventors: Barbaros Oezyilmaz, Giorgia Pastorin, Henrik Andersen
  • Patent number: 10295536
    Abstract: Clostridium difficile disease involves a range of clinical presentations ranging from mild to self-limiting diarrhea to life-threatening pseudomembranous colitis and megacolon. Cases of C. difficile are treated differently depending on severity of disease. Mild and moderate cases may be treated with metronidazole while moderate-to-severe and relapsing cases are often treated with vancomycin or fidaxomicin. The presence of C. difficile disease is detected using a biomarker panel that includes C. difficile antigen (GDH), toxins A and B, and fecal lactoferrin. In patients suspected of C. difficile disease, if GDH is detected indicating the presence of C. difficile, and then toxins A and/or B are detected to indicate toxigenic C. difficile and support a diagnosis of C. difficile-associated disease, fecal lactoferrin concentrations are measured to determine severity of the disease by indicating the amount of intestinal inflammation.
    Type: Grant
    Filed: April 10, 2014
    Date of Patent: May 21, 2019
    Assignee: TECHLAB, INC.
    Inventors: James Hunter Boone, David M. Lyerly, Tracy D. Wilkins, Robert J. Carman
  • Patent number: 10288603
    Abstract: Cells are grown in 3D culture and topological features obtained by photomicrography are correlated to cell viability and cell cell interactions.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: May 14, 2019
    Assignee: Greiner Bio-One North America, Inc.
    Inventor: Glauco R. Souza
  • Patent number: 10264796
    Abstract: A method for producing a seed of a plant resistant to seedling diseases is provided which includes contacting a non-pathogenic microbe corresponding to a seed-borne pathogen with a flower part of a host plant around the flowering time and collecting a seed of the host plant colonized by the non-pathogenic microbe obtained thereafter, and a method for controlling seedling diseases using the seed.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: April 23, 2019
    Assignee: NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY
    Inventors: Tsutomu Arie, Tohru Teraoka, Youko Nonaka, Akihiro Kato, Jun Tanaka, Tomomi Tokunaga, Kenichi Kurauchi, Tomotaka Suzuki
  • Patent number: 10238693
    Abstract: The present invention provides a novel way to replenish the disc using retooled disc compositions to repair degenerative discs. There is no better source of proteoglycans than the actual disc material (6) itself. To this end, there has been developed a technique to remove the nucleus pulposus and retool the morphology of the nucleus pulposus to create a powder material (10) that is dry and can be stored at room temperature for long periods of time. This powder (10) can then be reconstituted with a variety of fluids, the most suitable being normal saline or lactated ringers to form a flowable mixture (20).
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: March 26, 2019
    Assignee: Vivex Biomedical, Inc.
    Inventor: Harry Thomas Temple
  • Patent number: 10233477
    Abstract: The field of the invention is the analysis of target microorganisms in a complex sample. The present invention more particularly relates to a culture medium for the detection of at least one target microorganism including: at least one natural or synthetic fermentation or enzymatic activity substrate, and at least one selective agent, which inhibits non-target microorganisms, constituted by para-amino benzoic acid, one of its derivatives or one of their salts, at a concentration of between 0.05 and 1 g/L.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: March 19, 2019
    Assignee: BIOMERIEUX
    Inventor: Jean-Marc Roche
  • Patent number: 10227628
    Abstract: The present invention relates to a device for detecting a fungal contamination in an internal environment, to the use thereof and also to a method for detecting a fungal contamination in an internal environment using such a device.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: March 12, 2019
    Assignee: CENTRE SCIENTIFIQUE ET TECHNIQUE DU BATIMENT
    Inventors: Stephane Moularat, Yael Joblin, Enric Robine
  • Patent number: 10174360
    Abstract: The present disclosure provides a method for analyzing glyeart-derived monosaccharides in a sample. The present disclosure also provides a method for detecting or monitoring a disease or disorder in a patient. In addition, the present disclosure provides a method of determining aberrant glycotransferase activity. The present disclosure further provides a system for analyzing or comparing glycates in a sample.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: January 8, 2019
    Assignee: ARIZONA BOARD OF REGENTS, FOR AND ON BEHALF OF, ARIZONA STATE UNIVERSITY
    Inventors: Chad Borges, Douglas Rehder